David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using semaglutide therapy than when they are not using the drug, according to findings from a retrospective study.

The FDA is warning people with diabetes and the public that noninvasive smartwatches or smart rings that do not pierce the skin should not be used to measure blood glucose, according to a press release.

Healio spoke with David Klonoff, MD, about unmet needs in the field of diabetes technology.

Healio spoke with David Klonoff, MD, about disparities in access to diabetes technology.

Healio spoke with David Klonoff, MD, about how increasing use of telemedicine has impacted diabetes technology.

Healio spoke with David Klonoff, MD, about recently developed devices in diabetes technology.

Healio spoke with David Klonoff, MD, about recent advancements using available data in diabetes technology.

Healio spoke with David Klonoff, MD, about recent advancements in sensors in the field of diabetes technology.

Healio spoke with David Klonoff, MD, about the latest innovations in diabetes medications.

SAN DIEGO — In this video exclusive, David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE, discusses the potential for data and AI to improve diabetes care.